Double Biologic Therapy for Refractory Stricturing Crohn's Disease: A Successful Case of Deep Remission with Ustekinumab and Vedolizumab

Elmoursi, A; Barrett, TA; Perry, C

Perry, C (corresponding author), Univ Kentucky, Dept Internal Med, Div Gastroenterol, 800 Rose St,MN649, Lexington, KY 40536 USA.

INFLAMMATORY BOWEL DISEASES, 2020; 26 (7): E62

Abstract

Stricturing Crohn's disease (CD) is a severe phenotype that presents unique challenges to therapeutic management. Emerging literature suggests that an......

Full Text Link